These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 28522562

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aryl hydrocarbon receptor protects lung adenocarcinoma cells against cigarette sidestream smoke particulates-induced oxidative stress.
    Cheng YH, Huang SC, Lin CJ, Cheng LC, Li LA.
    Toxicol Appl Pharmacol; 2012 Mar 15; 259(3):293-301. PubMed ID: 22273977
    [Abstract] [Full Text] [Related]

  • 4. Exposure to PM2.5 Enhances the PI3K/AKT Signaling and Malignancy of ERα Expression-dependent Non-small Cell Lung Carcinoma.
    Tian L, Li Y, Liu HL, Lai WQ, Shi Y, Liu XH, Xi ZG, Lin BC.
    Biomed Environ Sci; 2021 Apr 20; 34(4):319-323. PubMed ID: 33894812
    [No Abstract] [Full Text] [Related]

  • 5. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH.
    Biochem Biophys Res Commun; 2005 Nov 04; 336(4):1221-6. PubMed ID: 16169518
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D.
    Cell Signal; 2013 Jun 04; 25(6):1395-402. PubMed ID: 23499909
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lysosomal function is involved in 17β-estradiol-induced estrogen receptor α degradation and cell proliferation.
    Totta P, Pesiri V, Marino M, Acconcia F.
    PLoS One; 2014 Jun 04; 9(4):e94880. PubMed ID: 24736371
    [Abstract] [Full Text] [Related]

  • 9. Interplay between estrogen receptor and AKT in estradiol-induced alternative splicing.
    Bhat-Nakshatri P, Song EK, Collins NR, Uversky VN, Dunker AK, O'Malley BW, Geistlinger TR, Carroll JS, Brown M, Nakshatri H.
    BMC Med Genomics; 2013 Jun 11; 6():21. PubMed ID: 23758675
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ERα phenotype, estrogen level, and benzo[a]pyrene exposure modulate tumor growth and metabolism of lung adenocarcinoma cells.
    Lin S, Lin CJ, Hsieh DP, Li LA.
    Lung Cancer; 2012 Mar 11; 75(3):285-92. PubMed ID: 21920623
    [Abstract] [Full Text] [Related]

  • 13. ERalpha signaling through slug regulates E-cadherin and EMT.
    Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Shetuni B, Barsky SH.
    Oncogene; 2010 Mar 11; 29(10):1451-62. PubMed ID: 20101232
    [Abstract] [Full Text] [Related]

  • 14. Arsenite and Cadmium Activate MAPK/ERK via Membrane Estrogen Receptors and G-Protein Coupled Estrogen Receptor Signaling in Human Lung Adenocarcinoma Cells.
    Huff MO, Todd SL, Smith AL, Elpers JT, Smith AP, Murphy RD, Bleser-Shartzer AS, Hoerter JE, Radde BN, Klinge CM.
    Toxicol Sci; 2016 Jul 11; 152(1):62-71. PubMed ID: 27071941
    [Abstract] [Full Text] [Related]

  • 15. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor.
    Grisouard J, Medunjanin S, Hermani A, Shukla A, Mayer D.
    Mol Endocrinol; 2007 Oct 11; 21(10):2427-39. PubMed ID: 17609434
    [Abstract] [Full Text] [Related]

  • 16. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M.
    Mol Endocrinol; 2006 Mar 11; 20(3):631-46. PubMed ID: 16239258
    [Abstract] [Full Text] [Related]

  • 17. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC, Schafer JM, Pearce ST, Osipo C, Chen B, Jordan VC.
    Gynecol Oncol; 2002 Jun 11; 85(3):498-506. PubMed ID: 12051881
    [Abstract] [Full Text] [Related]

  • 18. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells.
    Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, Adachi K, Tasaka K, Miyoshi E, Fujiwara N, Taniguchi N, Murata Y.
    J Biol Chem; 2001 Feb 02; 276(5):3459-67. PubMed ID: 11044445
    [Abstract] [Full Text] [Related]

  • 19. Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase.
    Greger JG, Fursov N, Cooch N, McLarney S, Freedman LP, Edwards DP, Cheskis BJ.
    Mol Cell Biol; 2007 Mar 02; 27(5):1904-13. PubMed ID: 17194752
    [Abstract] [Full Text] [Related]

  • 20. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A.
    Steroids; 2013 Nov 02; 78(11):1071-86. PubMed ID: 23891847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.